1 Neurobiology of Aging Laboratories, Fishberg Center for Neurobiology and 2 Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, New York 10029; and 3 Department of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Plasma levels of the adipocyte product adiponectin, a putative insulin-sensitizing agent, are reduced in obesity, whereas plasma levels of resistin, an agent that some believe to confer insulin resistance, are thought to increase with obesity. Because adrenalectomy can increase insulin sensitivity, we hypothesized that adrenalectomy would increase expression of adiponectin and decrease expression of resistin. Therefore, we measured adiponectin mRNA, adiponectin peptide, and resistin mRNA in adrenalectomized ob/ob mice. Adrenalectomy restored adiponectin expression in ob/ob mice to wild-type levels and stimulated adiponectin peptide to above wild-type levels. Surprisingly, expression of adiponectin and resistin was highly positively correlated even after statistical removal of effects of insulin, glucose, and adiposity. In addition, adiponectin and resistin expression were also highly correlated in diet-induced obese mice. The data support a role for adiponectin in mediating some effects of adrenalectomy on insulin sensitivity.
AdipoQ; adipocyte complement-related protein of 30 kDa; insulin resistance; glucocorticoids; leptin; messenger ribonucleic acid
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
SEVERAL GROUPS INDEPENDENTLY identified the same adipocyte-derived protein and variably named it AdipoQ (13), Acrp30 (22), adiponectin (15), or GBP28 (20). Adiponectin expression is reduced in both human obesity (13) and models of genetic obesity in mice (13). In addition, the peptide levels of adiponectin are reduced in obese humans (1). Furthermore, this reduction in adiponectin expression has been associated with insulin resistance (26, 27), suggesting that adiponectin functions to increase insulin sensitivity. Resistin, another adipocyte-derived peptide, was recently discovered (23). Resistin peptide levels are reported to increase in models of diet-induced obesity (23) and genetic models of murine obesity such as ob/ob and db/db mice (23). Insulin sensitivity of diet-induced obese mice increased when treated with antibodies to resistin (23), suggesting that resistin plays an opposing role to adiponectin, that of decreasing insulin sensitivity. However, there is growing evidence that resistin may not generally be associated with insulin resistance as first reported. Way et al. (24) have reported that resistin expression is reduced in various rodent models of obesity, and Janke et al. (14) have reported that there is no correlation between resistin expression and insulin resistance in humans.
Adrenalectomy reverses various metabolic defects, including hyperglycemia and hyperinsulinemia in many animal models of obesity (4, 10, 16). Adrenalectomy has also been shown to increase insulin sensitivity in gold-thio-glucose-induced obese mice as measured by insulin and glucose levels at both baseline and after a glucose load (3). More recently, Haluzik et al. (12) have demonstrated that adrenalectomy increases insulin sensitivity in both the liver and muscle of diabetic lipoatrophic mice using a hyperinsulinemic-euglycemic clamp. Based on reports of inhibition of adiponectin gene expression by dexamethasone in vitro (9, 11), we hypothesized that increased insulin sensitivity from adrenalectomy is associated with either increased expression of adiponectin or decreased expression of resistin. To verify this hypothesis, we have measured adiponectin expression, peptide levels, and resistin mRNA in adrenalectomized leptin-deficient ob/ob mice. We report here that adrenalectomy increased adiponectin mRNA and peptide in ob/ob mice, and adiponectin mRNA was surprisingly correlated positively with resistin mRNA. To confirm this positive correlation between the two genes, we have also measured adiponectin and resistin mRNA in diet-induced obese mice and report an even stronger statistical correlation between the two genes.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Animals. The appropriate Animal Institutional Review Board had approved all studies.
To assess gene expression in genetic obesity and effects of adrenalectomy, 2-mo-old male ob/ob mice and their wild-type littermates were adrenalectomized or sham adrenalectomized as reported (16). This resulted in the following four groups: wild-type sham operated (n = 4), wild-type adrenalectomized (n = 7), ob/ob sham operated (n = 6), and ob/ob adrenalectomized (n = 5). Ad libitum-fed mice were killed 2 wk after surgery between 1700 and 1900, just before lights out, adipose tissue was taken from the epididymal fat pad, and RNA was extracted as described previously (18). To assess effects of diet-induced obesity, mature male C57Bl/6J mice were fed either a high-fat, high-simple-carbohydrate diet (diet no. F2685; Bioserve, Frenchtown, NJ) or remained on normal rodent chow as previously described (2). The high-fat diet consisted of 35.5% fat, 35.0% simple carbohydrate, 20.0% protein, 0.1% fiber, and 3.7% ash (5.4 kcal/g), whereas the control rodent chow consisted of 5.0% fat, 55% complex carbohydrates, 22.0% protein, 5.0% fiber, and 6.0% ash (3.5 kcal/g). After 14 wk on the diet, mice were either fed ad libitum or fasted for 48 h and killed, adipose tissue was taken, and RNA was prepared as described above. This also resulted in the following four groups of mice: chow fed (n = 6), chow fasted (n = 3), high-fat diet fed (n = 6), and high-fat diet fasted (n = 5).Peripheral hormones. Blood glucose was measured by a Lifescan One-Touch II glucose meter (Johnson & Johnson, Mountain View, CA). Serum insulin and leptin were assayed by an ELISA with commercial kits (Crystal Chemical, Chicago, IL), and serum corticosterone and adiponectin were assayed by RIA with commercial kits (ICN Biomedicals, Costa Mesa CA and Linco Research, St. Charles, MO, respectively).
Northern blot analysis. Total RNA was extracted from white adipose tissue with TRIzol (GIBCO-BRL, Gaithersburg, MD), as described previously (18, 19). Templates for the production of both adiponectin and resistin probes were produced from 1 µg of mouse total adipose tissue RNA by RT-PCR, as described previously (18, 19). Primers for both adiponectin and resistin were designed using the MacVector program (Oxford Molecular Group) on a Macintosh platform. The standard criteria recommended by MacVector were used in choosing primers: 18-25 nt in length, 45-55% G + C content and melting temperature of 55-80°C. For adiponectin, the NH2-terminal primer used was 5'-GCAAGCTCTCCTGTTCCTCTTAATC-3', and the COOH-terminal primer used was 5'-TGCATCTCCTTTCTCTCCCTTCTC-3'. For resistin the NH2-terminal primer used was 5'-CCCTCCTTTTCCTTTTCTTCCTTG-3', and the COOH-terminal primer used was 5'-TTTTCTTCACGAATGTCCCACG-3'. Northern blot analysis was performed using single-stranded, internally labeled DNA probes created from the above templates for adiponectin and resistin. Blots and preparation of the leptin probe were carried out as described previously (18, 19). The membranes were reprobed with 18S rRNA to verify uniform RNA loading. The total integrated densities of hybridization signals were determined by a PhosphoImager (STORM 860; Molecular Dynamics, Sunnyvale, CA).
Statistics. The total integrated density for each Northern blot band was analyzed, and the mean and SE for each experimental group were calculated and presented as a percentage of either the mean wild-type sham group (study 1) or chow ad libitum-fed groups (study 2). Statistical analysis entailed a two-way ANOVA followed, when indicated by appropriate P values (P < 0.05), by the Tukey-Kramer post hoc test. Regression and multiple-regression analysis were used to examine the shared variance of each gene product with other products and hormones.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Effects of adrenalectomy and leptin deficiency.
Consistent with previous findings, the body weights for sham-operated
leptin-deficient ob/ob mice were significantly higher than
sham-operated wild-type mice (Table 1),
and adrenalectomy reduced body weight in the ob/ob mice but
not wild-type mice (Table 1). Similarly, adipose weights for
sham-operated ob/ob mice were significantly higher than
sham-operated wild-type mice (Table 1), and adrenalectomy reduced
adipose weight in the ob/ob mice but not in wild-type mice
(Table 1). The blood glucose levels for sham-operated ob/ob
mice were also significantly elevated compared with sham-operated
wild-type mice (Table 1), and adrenalectomy once again significantly
reduced blood glucose in the ob/ob mice but not in wild-type
mice (Table 1). Adrenalectomy of ob/ob mice dramatically
increased insulin sensitivity, as indicated by a >10-fold reduction of
insulin in adrenalectomized ob/ob compared with
sham-operated ob/ob mice (Table 1). In addition, serum
corticosterone was elevated in the sham-operated ob/ob mice
compared with the sham-operated wild-type mice (Table 1), and
adrenalectomy reduced the levels of corticosterone in both wild-type
and ob/ob mice, as expected (Table 1). Consistent with our
previous finding after adrenalectomy, levels of corticosterone were at
low physiological levels (16). The leptin peptide levels
for the wild-type sham-operated and adrenalectomized mice were
unchanged, and ob/ob mice did not exhibit any assayable
leptin peptide (Table 1).
|
|
|
Effects of diet and fasting.
Mice fed a high-fat, high-simple-carbohydrate diet had a significantly
higher body weight compared with mice fed a normal rodent chow diet
(Table 2), and fasting decreased body
weight in both chow and high-fat diet groups (Table 2). Similarly blood glucose was elevated in the mice fed the high-fat diet compared with
the chow-fed mice (Table 2), and fasting reduced glucose in both chow
and diet groups of mice (Table 2). Serum insulin was also elevated in
the mice fed a high-fat diet (Table 2), and fasting decreased insulin
in both chow and diet groups (Table 2).
|
|
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A key observation of the present study is that adrenalectomy reversed the reduction in adiponectin mRNA associated with leptin-deficient obesity and in fact led to an elevation of plasma adiponectin to above wild-type levels. Surprisingly, resistin mRNA was reduced in diet-induced obesity, in contrast to the elevation of plasma levels of resistin reported in diet-induced obesity by Steppan et al. (23) but in accordance with the findings of decreased resistin expression in various obese models by Way et al. (24). Furthermore, the expression of resistin and adiponectin was highly correlated across all conditions, even after statistical removal of the effects of other major hormonal variables. Although some of these results are surprising, they may be explained by simple hypotheses, as described below.
Adrenalectomy increases insulin sensitivity in ob/ob mice,
as evidenced by the dramatic decrease in plasma insulin and glucose (16). In the present study, we observed that adrenalectomy
normalized expression of adiponectin in ob/ob mice (Fig. 1,
A and B) and resulted in a twofold increase in
the peptide levels (Fig. 1C). This is consistent with in
vitro studies showing that dexamethasone inhibits adiponectin mRNA
(9, 11). In addition, Masuzaki et al. (17)
have shown that transgenic mice overexpressing the 11-hydroxysteroid
dehydrogenase type 1 gene exhibit elevated local levels of
corticosterone in adipose tissue and subsequently have lower
adiponectin expression (17). Because adiponectin has been
postulated to increase insulin sensitivity, our finding is consistent
with the hypotheses that adrenalectomy increases insulin sensitivity,
perhaps through the stimulation of adiponectin.
Although surgical removal of the entire adrenal gland may not be refined enough to isolate the responsible agents, others have used similar (4) or more refined surgical procedures such as adrenal cortectomies to remove just the adrenal cortex (5) or pharmacological agents such as RU-486 to block glucocorticoid receptors (21) and achieved similar physiological effects. In addition, replacement of glucocorticoids after adrenalectomy famously returns phenotypes that have been reversed by adrenalectomy (7). Conversely, elevations in glucocorticoids are known to lead to insulin resistance (25). This convergence of evidence suggests that the principal effect of adrenalectomy to increase insulin sensitivity is in fact because of the removal of glucocorticoids and not because of the removal of other hormonal factors from other components of the adrenal gland or its associated pathways.
Adiponectin mRNA and peptide were positively correlated in the leptin-deficient obese mice, with both mRNA and peptide levels showing an induction with adrenalectomy (Fig. 1, A-C). However, ob/ob mice showed lower adiponectin mRNA levels compared with wild-type mice (Fig. 1, A and B) despite the fact that the peptide levels of the two groups were similar (Fig. 1C), and adrenalectomized ob/ob mice showed higher plasma adiponectin compared with the wild-type sham-operated mice despite similar mRNA levels (Fig. 1, A-C). This apparent disparity may be explained by the significant difference in adiposity between the leptin-deficient obese mice and the wild-type mice (Table 1). In both cases, the plasma levels of adiponectin in ob/ob mice presumably reflect the increased adiposity of the leptin-deficient obese mice that persists even after adrenalectomy. A similar mechanism probably explains the seeming disparity between the decrease in resistin mRNA seen in diet-induced obesity and the reported elevation in resistin peptide in obesity (23). The elevated resistin peptide appears to reflect an increase in resistin-producing adipose tissue that quantitatively dominates the decrease in mRNA per microgram total RNA observed in the present study.
The degree of obesity and adipose tissue size may also explain the seemingly contradictory finding on adiponectin peptide levels with other forms of obesity. Although adiponectin peptide levels have been found to be decreased in both humans (1) and in diet-induced obesity in mice (27), we found in fact that leptin-deficient mice have similar peptide levels as their wild-type littermates (Fig. 1C). This may at first seem contradictory until closer examination of relative adipose tissue size within these obese models. The relatively much larger adiposity of the ob/ob mice, compared with humans and diet-induced obesity, may be sufficient to result in equal levels of the peptide with their wild-type littermates while in other forms of obesity this is not the case.
Adiponectin expression was reduced in the diet-induced obese mice compared with chow-fed mice (Fig. 3, A and B), confirming the findings of Yamauchi et. al. (27). Paradoxically, fasting led to a decrease in adiponectin mRNA in chow-fed mice, and similarly fasting led to a decrease in adiponectin mRNA in diet-induced obese mice as well (Fig. 3, A and B). The reduction in adiponectin expression with fasting is most likely because of the decrease in total adipose tissue as energy stores are depleted with nutritional deprivation.
The most surprising result in the current study was the high degree of correlation between resistin and adiponectin mRNAs across all conditions. This was true even after removal of other statistical variables such as body weight, adiposity, and other hormones. Thus, as can be observed in the regression shown in Fig. 4, resistin and adiponectin are correlated even when analyzed only in chow ad libitum-fed mice. Because in the second study resistin and adiponectin mRNAs were regulated concomitantly across all conditions, the high degree of correlation is readily apparent. In the first study, this correlation may perhaps seem paradoxical, since the regulation of these mRNAs differs in a key respect: that adiponectin mRNA is downregulated in ob/ob mice, whereas resistin mRNA is not. However, as with diet-induced obesity, inspection of the regression plot (Fig. 2) reveals that the regression occurs robustly within each group. This high degree of correlation leads us to conclude that adiponectin and resistin are regulated in a virtually identical fashion, at least in our two model systems. These results suggest that the regulation of expression of these two genes involves similar molecular mechanisms.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: C. V. Mobbs, Neurobiology of Aging Laboratories, Box 1639, Mt. Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029 (E-mail: charles.mobbs{at}mssm.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
August 13, 2002;10.1152/ajpendo.00227.2002
Received 23 May 2002; accepted in final form 7 August 2002.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Arita, Y,
Kihara S,
Ouchi N,
Takahashi M,
Maeda K,
Miyagawa J,
Hotta K,
Shimomura I,
Nakamura T,
Miyaoka K,
Kuriyama H,
Nishida M,
Yamashita S,
Okubo K,
Matsubara K,
Muraguchi M,
Ohmoto Y,
Funahashi T,
and
Matsuzawa Y.
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
Biochem Biophys Res Commun
257:
79-83,
1999[ISI][Medline].
2.
Bergen, HT,
Mizuno T,
Taylor J,
and
Mobbs CV.
Resistance to diet-induced obesity is associated with increased proopiomelanocortin mRNA and decreased neuropeptide Y mRNA in the hypothalamus.
Brain Res
850:
198-203,
1999.
3.
Blair, SC,
Caterson ID,
and
Cooney GJ.
Glucose tolerance and insulin secretion after adrenalectomy in mice made obese with gold thioglucose.
J Endocrinol
148:
391-398,
1996[Abstract].
4.
Bray, GA,
and
York DA.
The MONA LISA hypothesis in the time of leptin.
Recent Prog Horm Res
53:
95-117,
1998[Medline].
5.
Bray, GA,
York DA,
and
Fisler JS.
Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system.
Vitam Horm
45:
1-125,
1989[ISI][Medline].
6.
Chavez, M,
Seeley RJ,
Green PK,
Wilkinson CW,
Schwartz MW,
and
Woods SC.
Adrenalectomy increases sensitivity to central insulin.
Physiol Behav
62:
631-634,
1997[ISI][Medline].
7.
Chen, HL,
and
Romsos DR.
A single intracerebroventricular injection of dexamethasone elevates food intake and plasma insulin and depresses metabolic rates in adrenalectomized obese (ob/ob) mice.
J Nutr
125:
540-545,
1995[ISI][Medline].
8.
Dallman, MF,
Strack AM,
Akana SF,
Bradbury MJ,
Hanson ES,
Scribner KA,
and
Smith M.
Feast and famine: critical role of glucocorticoids with insulin in daily energy flow.
Front Neuroendocrinol
14:
303-347,
1993[ISI][Medline].
9.
Fasshauer, M,
Klein J,
Neumann S,
Eszlinger M,
and
Paschke R.
Hormonal regulation of adiponectin gene expressioni in 3T3-L1 adipocytes.
Biochem Biophys Res Commun
290:
1084-1089,
2002[ISI][Medline].
10.
Freedman, MR,
Stern JS,
Reaven GM,
and
Mondon CE.
Effect of adrenalectomy on in vivo glucose metabolism in insulin resistant Zucker obese rats.
Horm Metab Res
18:
296-298,
1986[ISI][Medline].
11.
Halleux, CM,
Takahashi M,
Delporte ML,
Detry R,
Funahashi T,
Matsuzawa Y,
and
Brichard SM.
Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue.
Biochem Biophys Res Commun
288:
1102-1107,
2001[ISI][Medline].
12.
Haluzik, M,
Dietz KR,
Kim JK,
Marcus-Samuels B,
Shulman GI,
Gavrilova O,
and
Reitman ML.
Adrenalectomy improves diabetes in A-ZIP/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity.
Diabetes
51:
2113-2118,
2002
13.
Hu, E,
Liang P,
and
Spiegelman BM.
AdipoQ is a novel adipose-specific gene dysregulated in obesity.
J Biol Chem
271:
10697-10703,
1996
14.
Janke, J,
Engeli S,
Gorzelniak K,
Luft FC,
and
Sharma AM.
Resistin gene expression in human adipocytes is not related to insulin resistance.
Obesity Res
10:
1-5,
2002
15.
Maeda, K,
Okubo K,
Shimomura I,
Funahashi T,
Matsuzawa Y,
and
Matsubara K.
cDNA cloning and expression of a novel adipose specific collagen-like Factor, apM1(Adipose Most Abundant Gene Transcript 1).
Biochem Biophys Res Commun
221:
286-289,
1996[ISI][Medline].
16.
Makimura, H,
Mizuno TM,
Roberts J,
Silverstein J,
Beasley J,
and
Mobbs CV.
Adrenalectomy reverses phenotype and restores hypothalamic melanocortin tone in leptin-deficient ob/ob mice.
Diabetes
49:
1917-1923,
2000[Abstract].
17.
Masuzaki, H,
Paterson J,
Shinyama H,
Morton HM,
Mullins JJ,
Seckl JR,
and
Flier JS.
A transgenic model of visceral obesity and the metabolic syndrome.
Science
294:
2166-2170,
2001
18.
Mizuno, TM,
Bergen H,
Funabashi T,
Kleopoulos SP,
Zhong YG,
Bauman WA,
and
Mobbs CV.
Obese gene expression: reduction by fasting and stimulation by insulin and glucose in lean mice, and persistent elevation in acquired (diet- induced) and genetic (yellow agouti) obesity.
Proc Natl Acad Sci USA
93:
3434-3438,
1996
19.
Mizuno, T,
Bergen H,
Kleopoulos S,
Bauman WA,
and
Mobbs CV.
Effects of nutritional status and aging on leptin gene expression in mice: importance of glucose.
Horm Metab Res
28:
679-684,
1996[ISI][Medline].
20.
Nakano, Y,
Tobe T,
Choi-Miura NH,
Mazda T,
and
Tomita M.
Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.
J Biochem (Tokyo)
120:
803-812,
1996[Abstract].
21.
Okada, S,
York DA,
and
Bray GA.
Mifepristone (RU486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obesity.
Am J Physiol Regul Integr Comp Physiol
262:
R1106-R1110,
1992
22.
Scherer, PE,
Williams S,
Fogliano M,
Baldini G,
and
Lodish HF.
A novel serum protein similar to C1q, produced exclusively in adipocytes.
J Biol Chem
270:
26746-26749,
1995
23.
Steppan, CM,
Bailey ST,
Bhat S,
Brown EJ,
Banerjee RR,
Wright CM,
Patel HR,
Ahima RS,
and
Lazar MA.
The hormone resistin links obesity to diabetes.
Nature
409:
307-312,
2001[ISI][Medline].
24.
Way, JM,
Corgun CZ,
Tong Q,
Uysal KT,
Brown KK,
Harrington WW,
Oliver WR, Jr,
Wilson TM,
Kliewer SA,
and
Hotamisligil S.
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists.
J Biol Chem
276:
25651-25653,
2001
25.
Weinstein, SP,
Paquin T,
Pritsker A,
and
Haber RS.
Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli.
Diabetes
44:
441-445,
1995[Abstract].
26.
Weyer, C,
Funahashi T,
Tanaka S,
Hotta K,
Matsuzawa Y,
Pratley RE,
and
Tataranni PA.
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.
J Clin Endocrinol Metab
86:
1930-1935,
2001
27.
Yamauchi, T,
Kamon J,
Waki H,
Terauchi Y,
Kubota N,
Hara K,
Mori Y,
Ide T,
Murakami K,
Tsuboyama-Kasaoka N,
Ezaki O,
Akanuma Y,
Gabrilova O,
Vinson C,
Reitman ML,
Kagechika H,
Shudo K,
Yoda M,
Nakano Y,
Tobe K,
Nagai R,
Kimura S,
Tomita M,
Froguel P,
and
Kadowaki T.
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.
Nat Med
7:
941-946,
2001[ISI][Medline].